ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …

Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell
infection in humans, impacting the host immune response. This virus causes a range of …

The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …

Human T-cell leukemia virus type 1 (HTLV-1), the first human retrovirus to be discovered, is
present in diverse regions of the world, where its infection is usually neglected in health care …

The first description of the human T-lymphotropic virus type 1 (HTLV-1) was made in 1980,
followed closely by the discovery of HTLV-2, in 1982. Since then, the main characteristics of …

Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Background Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that
causes a lifelong infection. Several diseases, including an aggressive form of leukaemia …

Objective: To assess the seroprevalence and risk factors for HTLV-I infection in Peruvian
women. Methods: Five hundred and sixty-eight healthy women> 20 years of age from three …

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human
retrovirus to be discovered, more than 25 years ago. HTLV-1 infects 15 to 20 million …